Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-06-06
1998-05-05
Owens, Amelia Averill
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514468, A61K 3135, A61K 31355
Patent
active
057475270
ABSTRACT:
Novel hypoglycemically active eremophilanolide sesquiterpenes which can be isolated from Psacalium spp., processes for obtaining the novel eremophilanolide sesquiterpenes and methods for their use as hypoglycemic agents, for example, in the treatment of diabetes are described. Further described is the use of epicacalone, cacalone, cacalol or dimaturin as hypoglycemic agents, for example, in the treatment of diabetes. In a preferred embodiment, the hypoglycemically active compounds are obtained from the roots of Psacalium decompositum. As agents for the treatment of diabetes, the hypoglycemically active compounds of the present inventions are useful for treating insulin-dependent (type I) and/or non-insulin-dependent (type II) diabetes.
REFERENCES:
Bohlmann et al, 1979, "Neu furanoeremophilane und weitere inhaltsstoffe aus sudafrikanischen senecio-arten", Phytochemistry 18:79-93.
Bye, Jr., 1986, "Medicinal plants of the Sierra Madre: Comparative study of Tarahumara and Mexican market plants", Economic Botany 40:103-124.
Hegnauer, 1989, Chemotaxonome Der Pflanzen (Birkhauser Verlag, Boston) pp. 280-281.
Huxtable, 1983, "Herbs along the western Mexican-American border", Proc. West. Pharmacol. Soc. 26:185-191.
Jankowski et al., 1984, "The unambiguous assignment of .sup.1 H and .sup.13 C signals in the NMR spectrum of cacalone acetate", Proc. Indian Acad. Sci. (Chem. Sci.) 93:1317-1321.
Krasovskaya et al., 1990, "Natural antioxidants: Furanoeremophilanes from Cacalia roots", Khimiya Prirodnykh Soedinenii 5:643-646.
Kuroyanagi et al., 1985, "Furanoeremophilane-type sesquiterpenes from Cacalia adenostyloides", Chem. Pharm. Bull. 33:4792-4797.
Lotina-Hennsen et al., 1991, "Inhibition of oxygen evolution by cacalol and its derivatives", Z. Naturforsch 46:777-780.
Manuel et al., 1992, "Actividad antimicrobiana del cacalol y sus derivados", Rev. Latinoamer. Quim. 23/1 and 22/4:14-17.
Marles and Farnsworth, 1994, "Plants as sources of antidiabetic agents", Economic and Medicinal Plant Research (Academic Press, New York) pp. 149-187.
Omura et al., 1978, "The sesquiterpenes of Cacalia species: 8-oxocacalol and the stereochemistry of cacalone epimers", Chem. Lett. pp. 1257-1260.
Perez et al., "A study of the hypoglucemic effect of some Mexican plants", J. Ethnopharmacology 12:253-262 (1984).
Rojas et al., 1994, "Phytochemistry of medicinal plants", 1994 Annual Meeting of the Phytochemical Society of North America (Poster 62).
Roman-Ramos et al., 1992, "Hypoglycermic activity of some antidiabetic plants", Archives Med. Res. 23:105-109.
Roman-Ramos et al., 1991, "Experimental study of the hypoglycemic effect some antidiabetic plants", Arch. Inves. Med. (Mex.) 22:87-93.
Romo and Nathan, 1964, "The constituents of Cacalea decomposita", Tetrahedron 20:2331-2337.
Soriano-Garcia et al., 1988, "Structure and stereochemistry of cacalone acetate, a sesquiterpene", Acta Cryst. 44:1092-1094.
Steinegger and Hansel, 1988, Lehrbuch der Pharmakognosie und Phytopharmazie (Springer-Verlag, New York).
Terabe et al., 1978 "Absolute stereochemistry of cacalol", Bull. Chem. Soc. Japan 51:661-662.
Winkelman, 1989, "Ethnobotanical treatments of diabetes in Baja California Norte", Medical Anthropology 11:255-268.
Gerald Sullivan, "Detection of Pyrrolizidine-type Alkaloids in Matarique (Cacalia Decomposita)", Vet. Hum. Toxicol. 23(1) (Feb. 1981).
Anaya et al., "Phytotoxicity of Cacalol and Some Derivatives Obtained from the Roots of Psacalium decompositum (A. Gray) H. Rob. & Brettell (Asteraceae), Matarique or Maturin", J. Chem. Ecology 22(3):393-403 (1996) .
Evans Joseph L.
Inman Wayne D.
King Steven Row
Luo Jian
Owens Amelia Averill
Shaman Pharmaceuticals, Inc.
LandOfFree
Furanoeremophilane and eremophilanolide sesquiterpenes for treat does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Furanoeremophilane and eremophilanolide sesquiterpenes for treat, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Furanoeremophilane and eremophilanolide sesquiterpenes for treat will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-55190